| Description |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Helix pharma |
Methotrexate 50mg/2ml
|
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Roche Pharma |
Trastuzumab 600mg/5ml |
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Searle Pharma |
|
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Roche Pharma |
|
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Getz Pharma |
Trastuzumab 440mg/10ml |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Roche Pharma |
Atezolizumab 1200mg/20ml |
| Content | Methotrexate is an antineoplastic agent used the treatment of a wide variety of cancers as well as severe psoriasis, severe rheumatoid arthritis, and juvenile rheumatoid arthritis.
| Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. It is specifically used for cancer that is HER2 receptor positive. It may be used by itself or together with other chemotherapy medication. | Rituximab, an anti CD20 monoclonal antibody, is used in the management of lymphoproliferative and autoimmune conditions. | "
Rituximab is a biological therapy used for rheumatoid arthritis, lupus, vasculitis and dermatomyositis | Trastuzumab is a monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers. | "
Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer, triple-negative breast cancer, small cell lung cancer, hepatocellular carcinoma, and alveolar soft part sarcoma. |
Reviews
There are no reviews yet.